Multiple genome-wide association studies (GWAS) have been performed to understand IBD susceptibility and more than 200 risk loci including in orosomucoid-like protein 3/ORMDL sphingolipid biosynthesis regulator 3 (ORMDL3) loci have been identified (2, 3). This evidence concerns the gene ORMDL3 and irritable bowel syndrome.